FibroGen

FibroGen Sells Chinese Subsidiary to AstraZeneca

US-based biotechnology company FibroGen announced the sale of its China subsidiary to AstraZeneca for approximately $160 million.

News

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

News

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

AstraZeneca

FibroGen

FibroGen Sells Chinese Subsidiary to AstraZeneca

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

Astellas, GSK Vie to Make 'High Altitude' Anaemia Pill

Top-Feature

20 Years of CHEManager International

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Brenntag Downsizes Management Board, Retains Both Divisions

API Manufacturing

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

Newsletter & e-edition